ScoreComparison
Why is Ascentage Pharma Group International Co., Ltd. ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 0%
- Poor long term growth as Operating profit has grown by an annual rate -18.51% of over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- OPERATING PROFIT(Q) Lowest at HKD -565.11 MM
- PRE-TAX PROFIT(Q) Lowest at HKD -606.34 MM
- NET PROFIT(Q) Lowest at HKD -616.45 MM
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 41.41%, its profits have risen by 56.9%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Ascentage Pharma Group International Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Ascentage Pharma Group International Co., Ltd.
43.99%
2.83
65.32%
Hang Seng Hong Kong
27.36%
1.03
25.88%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
91.26%
EBIT Growth (5y)
-18.51%
EBIT to Interest (avg)
-39.31
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
1.57
Sales to Capital Employed (avg)
0.15
Tax Ratio
2.64%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
103.00
EV to EBIT
-71.51
EV to EBITDA
-94.80
EV to Capital Employed
40.63
EV to Sales
27.66
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-56.81%
ROE (Latest)
-156.72%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Ascentage Pharma Group International Co., Ltd.
Net Sales
At HKD 170.21 MM has Grown at 98.72%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (HKD MM)
Operating Cash Flow
Highest at HKD -1,061.99 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (HKD MM)
Debtors Turnover Ratio
Highest at 7.45%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -10.44% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Ascentage Pharma Group International Co., Ltd.
Operating Profit
Lowest at HKD -565.11 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (HKD MM)
Pre-Tax Profit
Lowest at HKD -606.34 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (HKD MM)
Net Profit
Lowest at HKD -616.45 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (HKD MM)
EPS
Lowest at HKD -2.06
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (HKD)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
